Armstrong Advisory Group, Inc
- SEC CIK
- 0001932952
- Latest filing
- Jul 13, 2026
OTLK holding history
Outlook Therapeutics, Inc. in every 13F filed by Armstrong Advisory Group, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
OTLK overviewAll 13F holders of OTLKFull Q2 2026 holdings
- Shares (Q2 2026)
- 179
- Value
- $285
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 179 | $285 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 179 | $37 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 179 | $283 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 179 | $190 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 179 | $287 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 179 | $339 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 179 | $339 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 179 | $956 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 179 | $1.32K | <0.1% | −3,401−95.0% | Reduced | Holders |
| Q1 2024 | 3,580 | $1.41K | <0.1% | +3,401+1,900.0% | AddedConverted for a 1-for-20 split | Holders |
| Q4 2023 | 3,580 | $1.41K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 3,580 | $792 | <0.1% | +3,580 | New | Holders |